AIZANT DRUG RESEARCH SOLUTIONS PVT LTD

Company Profile:

AIZANT DRUG RESEARCH SOLUTIONS PVT LTD is a prominent Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) based in Hyderabad, India. Established in 2005, the company provides comprehensive research, development, and manufacturing services to the pharmaceutical, biotechnology, and generic industries worldwide. Aizant is recognized for its expertise in various stages of drug development, from early-phase research to commercial manufacturing support.

Factory or Trader:

AIZANT DRUG RESEARCH SOLUTIONS PVT LTD operates primarily as a Contract Development and Manufacturing Organization (CDMO). This means they possess significant manufacturing capabilities and facilities where they develop and produce pharmaceutical products and formulations under contract for their clients. Therefore, they are a manufacturing and development service provider, akin to a factory that produces goods for other companies, rather than a trading company that buys and sells finished products. They are not a trader.

Key Services:

The company's service portfolio includes:

Bioequivalence and Bioavailability Studies

Clinical Research (Phase I to Phase IV)

Pharmacokinetics and Biostatistics

Clinical Data Management

Analytical Research and Development

Formulation Development

Small-scale to commercial-scale manufacturing for pharmaceutical products.

Aizant is dedicated to delivering high-quality, regulatory-compliant solutions, assisting their clients through the complex journey of drug development and market entry.

Here are some of the product categories associated with AIZANT DRUG RESEARCH SOLUTIONS PVT LTD (based on publicly available information, which may not be exhaustive):

* Pharmaceutical Formulations

* Active Pharmaceutical Ingredients (APIs)

* Generics

* Finished Dosage Forms

Please note that the specific products within these categories may vary and are subject to change. For the most up-to-date product list, it is best to consult the company directly.